If you put aside the “breakthroughs”, “remarkables” and heralding new eras, the key is the statement that this all needs confirming by a randomised controlled trial with placebo which I suppose means Lu plus Nox drug vs Lu plus placebo.
In other words this ain’t coming to a regulatory agency any time soon.
The wide confidence interval for survival 9-30 months shows how imprecise the reported survival estimate is. No problems with that, just all down to being small trial. promising at best, But you don’t usually herald a new era with something like this.
- Forums
- ASX - By Stock
- NOX
- Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation, page-7
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 119457 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 187073 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 22101 | 0.115 |
2 | 75461 | 0.110 |
4 | 445000 | 0.105 |
6 | 244077 | 0.100 |
1 | 6000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 159073 | 5 |
0.125 | 144133 | 5 |
0.130 | 409378 | 5 |
0.135 | 205000 | 2 |
0.140 | 227281 | 6 |
Last trade - 10.15am 21/10/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online